Gemzar and interstitial lung disease Patient Reports February 13, 2012

Gemzar Side Effects Report #4564331-7
Gemzar side effect was reported by a Physician from on Jan 10, 2005. Male patient, 65 years of age, was diagnosed with ureteric cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, haematuria, interstitial lung disease, lung infiltration, lymphadenopathy mediastinal, pancytopenia, pleural effusion, pneumonia . Gemzar dosage: 1000 MG/M2. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4777829-3
Gemzar side effect was reported by a Physician from FRANCE on Aug 29, 2005. Male patient, 66 years of age, weighting 154.3 lb, was diagnosed with squamous cell carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, cough, crepitations, dyspnoea, interstitial lung disease, lung disorder, pneumonitis, pyrexia. Gemzar dosage: 1250 MG/M2/2 OTHER. During the same period patient was treated with CISPLATIN, NEULASTA, NOVATREX, PREDNISONE, SPECIAFOLDINE, ACTONEL. Patient was hospitalized. Patient died on 05/04/2005.

Gemzar Side Effects Report #5411945-8
Gemzar side effect was reported by a Physician from JAPAN on Aug 01, 2007. Female patient, 66 years of age, weighting 121.3 lb, was diagnosed with pleural mesothelioma malignant, insomnia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: decreased appetite, disease progression, inflammation, interstitial lung disease, pleural effusion, pneumonia . Gemzar dosage: 1500 MG, OTHER. During the same period patient was treated with CISPLATIN, CARBOPLATIN, LENDORMIN, NAVELBINE. Patient recovered.

Gemzar Side Effects Report #5759604-6
Gemzar side effect was reported by a Physician from JAPAN on May 27, 2008. Male patient, 63 years of age, was diagnosed with pleural mesothelioma malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: atrioventricular block, interstitial lung disease, malignant neoplasm progression, neutropenia, pneumocystis jiroveci pneumonia, pneumonia cytomegaloviral, pyrexia. Gemzar dosage: unknown. During the same period patient was treated with VINORELBINE. Patient died.


Gemzar Side Effects Report #5197084-2
Gemzar side effect was reported by a Physician from JAPAN on Dec 20, 2006. Male patient, 73 years of age, weighting 109.8 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bone marrow failure, chest x-ray abnormal, dyspnoea, haemoglobin decreased, hepatic enzyme increased, interstitial lung disease, platelet count decreased. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with KYTRIL, DECADRON #. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5186319-8
Gemzar side effect was reported by a Physician from JAPAN on Dec 01, 2006. Male patient, 73 years of age, weighting 109.8 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis of nausea and vomiting and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bone marrow failure, chest x-ray abnormal, dyspnoea, hepatic enzyme increased, interstitial lung disease, pleural effusion, rash . Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with KYTRIL, DECADRON #. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5174367-3
Gemzar side effect was reported by a Physician from JAPAN on Nov 08, 2006. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, interstitial lung disease, liver abscess, oedema, pleural effusion, pneumonia aspiration. Gemzar dosage: 1000 MG/M2, OTHER. Patient was hospitalized. Patient died.

Gemzar Side Effects Report #5179490-5
Gemzar side effect was reported by a Physician from JAPAN on Nov 08, 2006. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, cholangitis, interstitial lung disease, liver abscess, oedema, pleural effusion, pneumonia aspiration. Gemzar dosage: 1000 MG/M2, OTHER. Patient was hospitalized. Patient died on 08/01/2006.

Gemzar Side Effects Report #5940224-5
Gemzar side effect was reported by a Physician from JAPAN on Oct 23, 2008. Male patient, 67 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: computerised tomogram abnormal, dyspnoea exertional, interstitial lung disease, oxygen saturation decreased. Gemzar dosage: 1000 MG/M2, OTHER. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #5961375-5
Gemzar side effect was reported by a Physician from JAPAN on Nov 10, 2008. Male patient, 67 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: computerised tomogram abnormal, dyspnoea exertional, interstitial lung disease, oxygen saturation decreased. Gemzar dosage: 1000 MG/M2, OTHER. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4822105-3
Gemzar side effect was reported by a Health Professional from JAPAN on Oct 17, 2005. Male patient, 65 years of age, weighting 105.8 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiomegaly, interstitial lung disease. Gemzar dosage: 1400 MG. During the same period patient was treated with SUCRALFATE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4692373-X
Gemzar side effect was reported by a Health Professional from on June 01, 2005. Female patient, 61 years of age, weighting 99.21 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood ph increased, interstitial lung disease, lung infiltration, malignant neoplasm progression, white blood cell count decreased. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with MS CONTIN, LOXONIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5072966-0
Gemzar side effect was reported by a Physician from JAPAN on July 14, 2006. Female patient, 56 years of age, weighting 121.3 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood ph increased, cell marker increased, interstitial lung disease, tumour marker increased. Gemzar dosage: 380 MG, OTHER, INTRAVENOUS. During the same period patient was treated with NIZATIDINE, LOXONIN, ANPEC, MAGNESIUM OXIDE, BETAMETHASONE, POSTERISANTE, MONILAC. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4906417-0
Gemzar side effect was reported by a Physician from JAPAN on Jan 19, 2006. Female patient, 54 years of age, weighting 110.2 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, blood lactate dehydrogenase increased, c-reactive protein increased, cyanosis, hypoproteinaemia, hypoxia, interstitial lung disease, lung infiltration, malaise. Gemzar dosage: 1500 MG, OTHER, INTRAVENOUS. Patient died on 11/06/2004.


Gemzar Side Effects Report #5823488-8
Gemzar side effect was reported by a Physician from JAPAN on July 16, 2008. Male patient, weighting 112.0 lb, was diagnosed with pancreatic carcinoma stage iv, diabetes mellitus and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, metastases to large intestine, metastases to lung, metastases to peritoneum. Gemzar dosage: 1600 MG, OTHER. During the same period patient was treated with BASEN. Patient died on 06/08/2008.

Gemzar Side Effects Report #5846580-0
Gemzar side effect was reported by a Physician from JAPAN on Aug 01, 2008. Female patient, weighting 88.18 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, pancreatic pseudocyst. Gemzar dosage: unknown. During the same period patient was treated with NASEA, DECADRON. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5850777-3
Gemzar side effect was reported by a Physician from JAPAN on Aug 08, 2008. Female patient, weighting 88.18 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, pancreatic pseudocyst. Gemzar dosage: unknown. During the same period patient was treated with NASEA, DECADRON. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5973188-9
Gemzar side effect was reported by a Physician from JAPAN on Nov 20, 2008. Male patient was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: computerised tomogram abnormal, dyspnoea exertional, interstitial lung disease, lymphocyte stimulation test positive, oxygen saturation decreased. Gemzar dosage: 1600 MG/M2, OTHER. During the same period patient was treated with ADALAT, MICARDIS, WYSTAL, FAMOTIDINE, REMINARON, ZYLORIC, URALYT, APLACE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5892552-X
Gemzar side effect was reported by a Physician from JAPAN on Sept 12, 2008. Male patient, weighting 141.1 lb, was diagnosed with pancreatic carcinoma stage iii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, hyponatraemia, hypoproteinaemia, interstitial lung disease, oedema, pleural effusion, pleurisy. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with NAUZELIN, ADALAT CR, DIOVAN, RABEPRAZOLE, URSO, FOIPAN, TAURINE. Patient was hospitalized and became disabled. Patient recovered.


Gemzar Side Effects Report #5912452-6
Gemzar side effect was reported by a Physician from JAPAN on Sept 26, 2008. Male patient, weighting 141.1 lb, was diagnosed with pancreatic carcinoma stage iii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, hyponatraemia, hypoproteinaemia, interstitial lung disease, oedema, pleural effusion, pleurisy. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with NAUZELIN, ADALAT CR, DIOVAN, RABEPRAZOLE, URSO, FOIPAN, TAURINE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5957238-1
Gemzar side effect was reported by a Physician from UNITED STATES on Nov 05, 2008. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma stage ii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, pneumonia . Gemzar dosage: 1000 MG/M2, DAYS 1, 8 + 15 EVERY 21 DAYS. Patient recovered.

Gemzar Side Effects Report #6083828-4
Gemzar side effect was reported by a Physician from JAPAN on Feb 16, 2009. Male patient, weighting 110.2 lb, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with AMLODIN, BEZATOL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5227426-0
Gemzar side effect was reported by a Physician from FRANCE on Jan 26, 2007. Male patient, 49 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease. Gemzar dosage: 1000 MG/M2, OTHER. Patient died on 10/02/2006.

Gemzar Side Effects Report #5797921-4
Gemzar side effect was reported by a Physician from FRANCE on June 18, 2008. Male patient, 80 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, oedema peripheral, pleural effusion. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #5757132-5
Gemzar side effect was reported by a Physician from JAPAN on May 26, 2008. Male patient, 75 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: chills, interstitial lung disease, klebsiella infection, loss of consciousness, pneumonia bacterial. Gemzar dosage: 1000 MG, OTHER. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #6080011-3
Gemzar side effect was reported by a Health Professional from JAPAN on Feb 16, 2009. Male patient, 75 years of age, weighting 97.00 lb, was diagnosed with pancreatic carcinoma, hypertension and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with TANATRIL, NORVASC, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5337542-0
Gemzar side effect was reported by a Physician from UNITED STATES on Aug 08, 2006. Female patient, 72 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease. Gemzar dosage: unknown. During the same period patient was treated with TARCEVA. Patient recovered.

Gemzar Side Effects Report #4770913-X
Gemzar side effect was reported by a Physician from JAPAN on Aug 29, 2005. Male patient, 72 years of age, weighting 123.5 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: aspergillosis, candidiasis, interstitial lung disease, pneumonia klebsiella, pneumonitis, pseudomonas infection, respiratory failure, serratia infection. Gemzar dosage: 1100 MG OTHER. During the same period patient was treated with KYTRIL, DECADRON, FAMOTIDINE. Patient died on 08/15/2005.

Gemzar Side Effects Report #5239766-X
Gemzar side effect was reported by a Physician from JAPAN on Feb 06, 2007. Male patient, 71 years of age, weighting 138.9 lb, was diagnosed with pancreatic carcinoma, pain  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, bile duct stenosis, bone marrow failure, disseminated intravascular coagulation, interstitial lung disease, malaise, malignant neoplasm progression, nausea , oedema. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with OMEPRAL, CAMOSTAT MESILATE, FUROSEMIDE, PENTAGIN, MAGMITT. Patient was hospitalized. Patient died on 10/29/2006.


Gemzar Side Effects Report #5154971-9
Gemzar side effect was reported by a Physician from JAPAN on Nov 08, 2006. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, interstitial lung disease, liver abscess, oedema, pleural effusion, post procedural bile leak. Gemzar dosage: 1000 MG/M2, OTHER. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4638286-0
Gemzar side effect was reported by a Physician from on Mar 28, 2005. Male patient, 65 years of age, weighting 105.8 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease. Gemzar dosage: 1400 MG. During the same period patient was treated with BETAMETHASONE ACETATE, KYTRIL, ULCDERLMIN, ZOLPIDEM TARTRATE. Patient recovered.

Gemzar Side Effects Report #5675436-1
Gemzar side effect was reported by a Physician from UNITED STATES on Feb 20, 2007. Male patient, 64 years of age, weighting 203.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, interstitial lung disease, rash . Gemzar dosage: 1600 MG, INTRAVENOUS. During the same period patient was treated with TARCEVA. Patient recovered.

Gemzar Side Effects Report #5206080-8
Gemzar side effect was reported by a Physician from GERMANY on Jan 02, 2007. Male patient, 60 years of age, weighting 196.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cough, dyspnoea, interstitial lung disease, lung infiltration. Gemzar dosage: 1000 MG/M2, UNK. Patient recovered.

Gemzar Side Effects Report #5286549-0
Gemzar side effect was reported by a Physician from GERMANY on Mar 28, 2007. Male patient, 60 years of age, weighting 196.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain upper, cough, dyspnoea, interstitial lung disease, lung infiltration. Gemzar dosage: 1000 MG/M2, UNK. Patient recovered.


Gemzar Side Effects Report #5675286-6
Gemzar side effect was reported by a Physician from UNITED STATES on Dec 13, 2007. Male patient, 60 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5706567-5
Gemzar side effect was reported by a Physician from FRANCE on Apr 03, 2008. Male patient, 56 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholecystitis, disseminated intravascular coagulation, interstitial lung disease, thrombocytopenia. Gemzar dosage: 1970 MG, OTHER. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5796161-2
Gemzar side effect was reported by a Physician from FRANCE on June 17, 2008. Male patient, 56 years of age, weighting 156.5 lb, was diagnosed with pancreatic carcinoma, escherichia bacteraemia, depression , pain  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholecystitis, disseminated intravascular coagulation, dyspnoea, interstitial lung disease, thrombocytopenia. Gemzar dosage: 1970 MG, ON DAY 1, 8 AND 15 OF 4 WEEKLY CYCLES. During the same period patient was treated with CLAMOXYL, SEROPLEX, SKENAN, OFLOCET. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4578543-X
Gemzar side effect was reported by a Physician from on Jan 20, 2005. Female patient, 54 years of age, weighting 110.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory failure, blood lactate dehydrogenase increased, c-reactive protein increased, dyspnoea, haemoglobin decreased, interstitial lung disease, lung infiltration, pleural effusion. Gemzar dosage: 1500 MG OTHER. Patient recovered.

Gemzar Side Effects Report #5675308-2
Gemzar side effect was reported by a Physician from UNITED STATES on Sept 18, 2007. Female patient, 48 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease. Gemzar dosage: 50 MG/M2, 2/W. During the same period patient was treated with NEXIUM, METOCLOPRAMIDE, COMPAZINE, NEURONTIN, PREMARIN, METHADONE. Patient recovered.


Gemzar Side Effects Report #5871666-4
Gemzar side effect was reported by a Physician from UNITED STATES on Aug 21, 2008. Female patient, 83 years of age, was diagnosed with ovarian cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, interstitial lung disease, malignant neoplasm progression, pneumonia , pulmonary embolism , pyrexia. Gemzar dosage: 800 MG/M2; ON DAYS 1, 14, AND 28, EVERY 4 WEEKS FOR COMPLETION OF 1.5 CYCLES. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4870317-5
Gemzar side effect was reported by a Physician from JAPAN on Dec 12, 2005. Male patient, 69 years of age, weighting 132.7 lb, was diagnosed with non-small cell lung cancer stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, leukopenia, malignant neoplasm progression. Gemzar dosage: 1250 MG, OTHER, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, MOHRUS, NITROPEN, ISODINE, ZANTAC. Patient was hospitalized. Patient died on 07/07/2003.

Gemzar Side Effects Report #4870217-0
Gemzar side effect was reported by a Physician from JAPAN on Dec 12, 2005. Male patient, 67 years of age, weighting 125.7 lb, was diagnosed with non-small cell lung cancer stage iiib and was treated with Gemzar. After drug was administered, patient experienced the following side effects: erythema, febrile neutropenia, interstitial lung disease, malignant neoplasm progression, stomatitis. Gemzar dosage: 1300 MG, OTHER; INTRAVENOUS. During the same period patient was treated with TAXOTERE, PURSENNID, VOLTAREN, ASCORBIC ACID, ALINAMIN EX, GASTER OD. Patient was hospitalized. Patient died on 03/31/2003.

Gemzar Side Effects Report #4870280-7
Gemzar side effect was reported by a Physician from JAPAN on Dec 12, 2005. Male patient, 72 years of age, weighting 105.8 lb, was diagnosed with non-small cell lung cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, malignant neoplasm progression, stridor. Gemzar dosage: 1110 MG, OTHER, INTRAVENOUS. During the same period patient was treated with TAXOTERE, DECADRON, RESTAMIN, MS CONTIN, LOXONIN, ADALAT, MUCOSOLVAN. Patient died on 07/31/2002.

Gemzar Side Effects Report #4870281-9
Gemzar side effect was reported by a Physician from JAPAN on Dec 12, 2005. Male patient, 70 years of age, weighting 133.4 lb, was diagnosed with non-small cell lung cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: adrenomegaly, body temperature decreased, bone pain, cyanosis, interstitial lung disease, lymphadenopathy, malignant neoplasm progression, pleural effusion, pulmonary fibrosis . Gemzar dosage: 1300 MG, OTHER, INTRAVENOUS. During the same period patient was treated with TAXOTERE, LOXONIN, ZYRTEC, CODEINE PHOSPHATE, MAGNESIUM OXIDE, ZANTAC, GASMOTIN, METHYCOBAL. Patient was hospitalized. Patient died on 01/12/2003.

Gemzar Side Effects Report #4870680-5
Gemzar side effect was reported by a Physician from JAPAN on Dec 12, 2005. Male patient, 67 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood ph increased, dyspnoea exertional, interstitial lung disease, nausea . Gemzar dosage: 1150 MG, OTHER, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, HALCION. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4870924-X
Gemzar side effect was reported by a Physician from JAPAN on Dec 12, 2005. Male patient, 58 years of age, weighting 160.5 lb, was diagnosed with non-small cell lung cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, febrile neutropenia, infection , influenza, interstitial lung disease, nasopharyngitis, oxygen saturation decreased, stridor. Gemzar dosage: 1350 MG, OTHER, INTRAVENOUS. During the same period patient was treated with DOCETAXEL, HARNAL, ACTOS, AMARYL, MAGNESIUM OXIDE, CODEINE PHOSPHATE, MEDICON. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5925783-0
Gemzar side effect was reported by a Physician from BELGIUM on Oct 10, 2008. Male patient, 57 years of age, was diagnosed with non-small cell lung cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, interstitial lung disease. Gemzar dosage: unknown. During the same period patient was treated with ALIMTA, MEDROL. Patient recovered.

Gemzar Side Effects Report #5227401-6
Gemzar side effect was reported by a Physician from FRANCE on Jan 25, 2007. Female patient, 52 years of age, weighting 92.59 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, interstitial lung disease, urticaria. Gemzar dosage: 1737 MG, OTHER. During the same period patient was treated with CISPLATIN, ZOFRAN, TRANXENE. Patient was hospitalized. Patient died on 10/27/2006.

Gemzar Side Effects Report #5239769-5
Gemzar side effect was reported by a Physician from JAPAN on Feb 06, 2007. Male patient, 66 years of age, weighting 145.5 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, malignant neoplasm progression, staphylococcal infection . Gemzar dosage: 1200 MG, UNK. Patient was hospitalized and became disabled. Patient died on 08/29/2006.


Gemzar Side Effects Report #5152512-3
Gemzar side effect was reported by a Consumer or non-health professional from FRANCE on Nov 07, 2006. Female patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, urticaria. Gemzar dosage: unknown. Patient was hospitalized. Patient died on 11/03/2006.

Gemzar Side Effects Report #5158649-7
Gemzar side effect was reported by a Physician from JAPAN on Nov 14, 2006. Male patient was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease. Gemzar dosage: 1000 MG/M2, OTHER. Patient recovered.

Gemzar Side Effects Report #5475919-3
Gemzar side effect was reported by a Physician from GERMANY on Sept 19, 2007. Male patient, weighting 165.3 lb, was diagnosed with non-small cell lung cancer, pulmonary fibrosis  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, pneumonia , po2 decreased, pyrexia. Gemzar dosage: unknown. During the same period patient was treated with CORTISONE ACETATE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4546634-5
Gemzar side effect was reported by a Physician from on Dec 15, 2004. Female patient was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease. Gemzar dosage: 800 MG/M2 OTHER. During the same period patient was treated with DOCETAXEL. Patient recovered.

Gemzar Side Effects Report #5038470-0
Gemzar side effect was reported by a Pharmacist from UNITED STATES on June 28, 2006. Male patient, 47 years of age, weighting 231.5 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bronchiolitis, cough, diffuse alveolar damage, dyspnoea, interstitial lung disease, lung infiltration, pneumonia . Gemzar dosage: 1000 MG/M2 (2300 MG). Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4600323-7
Gemzar side effect was reported by a Physician from on Feb 15, 2005. Male patient, 64 years of age, weighting 165.3 lb, was diagnosed with neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: atelectasis, febrile neutropenia, graft complication, haematuria, infection , interstitial lung disease, lung infiltration, lymphadenitis, lymphadenopathy mediastinal. Gemzar dosage: 1000 MG/M2. During the same period patient was treated with CISPLATIN, RANITIDIN, AMBROXOL, ENOXAPARIN, VERAPAMIL. Patient was hospitalized and became disabled. Patient recovered.

Gemzar Side Effects Report #4824578-9
Gemzar side effect was reported by a Physician from JAPAN on Oct 26, 2005. Male patient, 68 years of age, weighting 121.3 lb, was diagnosed with metastases to lung and was treated with Gemzar. After drug was administered, patient experienced the following side effects: antinuclear antibody positive, bile duct stenosis, cholangitis sclerosing, hepatic failure, immune system disorder, interstitial lung disease, pancreatic disorder, pancreatitis, pleural effusion. Gemzar dosage: 1600 MG; OTHER. During the same period patient was treated with FLUOROURACIL, LEUCOVORINE. Patient was hospitalized. Patient died on 05/20/2003.

Gemzar Side Effects Report #4883729-0
Gemzar side effect was reported by a Physician from UNITED STATES on Jan 04, 2006. Male patient, 62 years of age, weighting 190.0 lb, was diagnosed with mesothelioma  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bronchitis acute, interstitial lung disease, lung disorder, malignant neoplasm progression, pneumonia , pulmonary toxicity, respiratory failure. Gemzar dosage: unknown. During the same period patient was treated with ALIMTA. Patient died.

Gemzar Side Effects Report #4957297-9
Gemzar side effect was reported by a Physician from UNITED STATES on Mar 14, 2006. Male patient, 62 years of age, weighting 190.0 lb, was diagnosed with mesothelioma  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory failure, bronchitis acute, bronchopneumonia, diffuse alveolar damage, haemoglobin decreased, haemorrhage, interstitial lung disease, malignant neoplasm progression, pleural fibrosis. Gemzar dosage: 800 MG, INTRAVENOUS. During the same period patient was treated with ALIMTA, PROCRIT, ARANESP, RANITIDINE, DECADRON, VITAMIN B12, FOLIC ACID, BENADRYL. Patient died.

Gemzar Side Effects Report #4777826-8
Gemzar side effect was reported by a Physician from JAPAN on Aug 26, 2005. Male patient, 74 years of age, weighting 116.8 lb, was diagnosed with malignant neoplasm of renal pelvis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood ph decreased, cachexia, hypoxia, interstitial lung disease, malignant neoplasm progression, neutrophil count decreased, pneumonia bacterial. Gemzar dosage: 2500 MG/M2 EVERY OTHER WEEK. During the same period patient was treated with TAXOL. Patient died on 04/12/2004.


Gemzar Side Effects Report #5879485-X
Gemzar side effect was reported by a Physician from JAPAN on Aug 29, 2008. Male patient, 74 years of age, weighting 136.7 lb, was diagnosed with lung squamous cell carcinoma stage iii, cerebral infarction, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, anaemia, disseminated intravascular coagulation, interstitial lung disease, pneumocystis jiroveci pneumonia, pneumonia cytomegaloviral, pulmonary alveolar haemorrhage, renal impairment. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with NAVELBINE, ASPIRIN, KYTRIL. Patient died on 08/29/2008.

Gemzar Side Effects Report #4639083-2
Gemzar side effect was reported by a Physician from on Mar 29, 2005. Male patient, 79 years of age, weighting 134.5 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: eczema , eosinophil percentage increased, epistaxis, hypersensitivity, interstitial lung disease, neutrophil count decreased, platelet count decreased, vasculitis , white blood cell count decreased. Gemzar dosage: 1670 MG OTHER. During the same period patient was treated with NAVELBINE, SELBEX, MOBIC, FERROMIA, LOXOPROFEN, FAMOTIDINE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4640629-9
Gemzar side effect was reported by a Physician from on Mar 29, 2005. Male patient, 79 years of age, weighting 134.5 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: eczema , eosinophil count increased, epistaxis, hypersensitivity, interstitial lung disease, neutrophil count decreased, platelet count decreased, vasculitis , white blood cell count decreased. Gemzar dosage: 1670 MG OTHER. During the same period patient was treated with NAVELBINE, SELBEX, MOBIC, FERROMIA, LOXOPROFEN, FAMOTIDINE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4662772-0
Gemzar side effect was reported by a Physician from on Apr 21, 2005. Male patient, 79 years of age, weighting 134.5 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cough, eczema , eosinophil percentage increased, epistaxis, hypersensitivity, injection site reaction, interstitial lung disease, laboratory test abnormal, neutrophil percentage decreased. Gemzar dosage: 1670 MG OTHER. During the same period patient was treated with NAVELBINE, SELBEX, MOBIC, FERROMIA, LOXOPROFEN, FAMOTIDINE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5234655-9
Gemzar side effect was reported by a Physician from JAPAN on Jan 29, 2007. Male patient, 72 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , gastroenteritis staphylococcal, interstitial lung disease, muscle atrophy, muscle fatigue, myopathy steroid, subclavian vein thrombosis. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with CARBOPLATIN, VINORELBINE TARTRATE. Patient died on 05/15/2004.

Gemzar Side Effects Report #5270276-X
Gemzar side effect was reported by a Physician from JAPAN on Mar 12, 2007. Male patient, 72 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cytomegalovirus infection , gastroenteritis staphylococcal, interstitial lung disease, muscle atrophy, muscle fatigue, myopathy steroid, subclavian vein thrombosis. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with CARBOPLATIN, VINORELBINE TARTRATE. Patient died on 05/15/2004.

Gemzar Side Effects Report #5675435-X
Gemzar side effect was reported by a Health Professional from UNITED STATES on Mar 01, 2007. Female patient, 65 years of age, weighting 247.6 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, renal disorder. Gemzar dosage: 900 MG. During the same period patient was treated with DIURETICS, OXYGEN, GLYBURIDE AND METFORMIN, ACTOS, SINGULAIR, ACIPHEX, ZYRTEC. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4910902-5
Gemzar side effect was reported by a Consumer or non-health professional from FRANCE on Jan 31, 2006. Female patient, 59 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, chest x-ray abnormal, febrile neutropenia, interstitial lung disease, pyrexia. Gemzar dosage: 1910 MG, OTHER, INTRAVENOUS : 1625 MG, OTHER, INTRAVENOUS. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5186327-7
Gemzar side effect was reported by a Physician from JAPAN on Nov 14, 2006. Male patient, 68 years of age, weighting 132.3 lb, was diagnosed with lung adenocarcinoma stage iii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, interstitial lung disease, lymphangiosis carcinomatosa. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with MAGNESIUM OXIDE, PURSENNID, MARZULENE S, LOXONIN, PARIET, MYSLEE, ISODINE, CYANOCOBALAMIN. Patient died on 10/08/2006.

Gemzar Side Effects Report #5407399-8
Gemzar side effect was reported by a Physician from JAPAN on Aug 01, 2007. Female patient, 53 years of age, was diagnosed with lung adenocarcinoma stage ii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, gastrointestinal haemorrhage, hepatic failure, interstitial lung disease, multi-organ failure, renal failure. Gemzar dosage: unknown. Patient was hospitalized. Patient died on 08/23/2006.


Gemzar Side Effects Report #5430548-2
Gemzar side effect was reported by a Physician from JAPAN on Aug 27, 2007. Female patient, 53 years of age, was diagnosed with lung adenocarcinoma stage ii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, continuous haemodiafiltration, diffuse alveolar damage, gastrointestinal haemorrhage, hepatic failure, interstitial lung disease, lung infiltration, multi-organ failure. Gemzar dosage: unknown. Patient was hospitalized. Patient died on 08/23/2006.

Gemzar Side Effects Report #4565326-X
Gemzar side effect was reported by a Physician from on Jan 14, 2005. Female patient, 63 years of age, weighting 112.0 lb, was diagnosed with lung adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, lichen planus, neutropenia, pyrexia, rhinorrhoea. Gemzar dosage: 1000MG/M2 OTHER. During the same period patient was treated with TAXOTERE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5786056-2
Gemzar side effect was reported by a Physician from GERMANY on June 13, 2008. Male patient, 67 years of age, was diagnosed with hodgkin's disease  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alveolitis, interstitial lung disease, pulmonary fibrosis . Gemzar dosage: 1000 MG/M2 ON DAY 1 AND 8 EVERY 21 DAYS, OTHER. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5371734-X
Gemzar side effect was reported by a Physician from JAPAN on June 18, 2007. Male patient, 81 years of age, weighting 85.98 lb, was diagnosed with gallbladder cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: haemoglobin decreased, interstitial lung disease, platelet count decreased. Gemzar dosage: 1000 MG/M2, UNK. During the same period patient was treated with HARNAL, SENNOSIDE A, LEUCON. Patient was hospitalized. Patient died on 06/13/2007.

Gemzar Side Effects Report #4655318-4
Gemzar side effect was reported by a Health Professional from on Apr 14, 2005. Female patient, 58 years of age, was diagnosed with breast cancer metastatic, metastases to bone, metastases to pleura and was treated with Gemzar. After drug was administered, patient experienced the following side effects: dyspnoea, interstitial lung disease. Gemzar dosage: 1000 MG/M2 OTHER. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5337813-8
Gemzar side effect was reported by a Physician from UNITED STATES on Mar 14, 2006. Female patient, 54 years of age, weighting 180.8 lb, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, interstitial lung disease. Gemzar dosage: unknown. During the same period patient was treated with ZOFRAN, ZOMETA. Patient recovered.

Gemzar Side Effects Report #5530761-X
Gemzar side effect was reported by a Physician from JAPAN on Nov 19, 2007. Male patient, weighting 134.5 lb, was diagnosed with biliary cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, cholangitis, interstitial lung disease, pleural effusion, pyrexia, urine output decreased. Gemzar dosage: 1700 MG, OTHER. During the same period patient was treated with MAGLAX, LENDORMIN, GASTER, DECADRON, KYTRIL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5977819-9
Gemzar side effect was reported by a Physician from JAPAN on Nov 28, 2008. Female patient was diagnosed with bile duct cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, malignant neoplasm progression. Gemzar dosage: 1000 MG, OTHER. Patient was hospitalized. Patient died on 12/18/2006.

Gemzar Side Effects Report #5446158-7
Gemzar side effect was reported by a Consumer or non-health professional from JAPAN on Aug 28, 2007. Female patient, 78 years of age, weighting 114.6 lb, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, respiratory failure, sepsis . Gemzar dosage: 800 MG, OTHER. During the same period patient was treated with JUZENTAIHOTO, URSO, GASMOTIN, MUCOSTA. Patient was hospitalized. Patient died on 12/28/2005.

Gemzar Side Effects Report #5475935-1
Gemzar side effect was reported by a Consumer or non-health professional from JAPAN on Sept 20, 2007. Female patient, 78 years of age, weighting 114.6 lb, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure acute, interstitial lung disease, sepsis . Gemzar dosage: 800 MG, OTHER. During the same period patient was treated with JUZENTAIHOTO, URSO, GASMOTIN, MUCOSTA. Patient was hospitalized. Patient died on 12/28/2005.


Gemzar Side Effects Report #4565323-4
Gemzar side effect was reported by a Health Professional from on Jan 07, 2005. Male patient, 68 years of age, weighting 147.7 lb, was diagnosed with bile duct cancer, ascites and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, ascites, interstitial lung disease. Gemzar dosage: 1680 MG OTHER. During the same period patient was treated with LASIX, ALDACTONE. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5928246-1
Gemzar side effect was reported by a Physician from BELGIUM on Oct 14, 2008. Female patient, 50 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: inflammation, interstitial lung disease. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5950041-8
Gemzar side effect was reported by a Physician from BELGIUM on Oct 30, 2008. Female patient, 50 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: inflammation, interstitial lung disease, thrombocytopenia. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5715980-1
Gemzar side effect was reported by a Physician from JAPAN on Apr 15, 2008. Female patient, weighting 110.2 lb, was diagnosed with bile duct cancer, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, metastases to lung. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with SEROTONE, DECADRON, RINDERON, MYSLEE, THYRADIN S, LOXONIN, CYTOTEC, LANSOPRAZOLE. Patient died on 01/04/2008.

Gemzar Side Effects Report #5740447-4
Gemzar side effect was reported by a Physician from JAPAN on May 08, 2008. Female patient, weighting 110.2 lb, was diagnosed with bile duct cancer, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, metastases to lung, metastases to peritoneum. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with SEROTONE, DECADRON, RINDERON, MYSLEE, THYRADIN S, LOXONIN, CYTOTEC, TAKEPRON. Patient died on 01/04/2008.

Gemzar Side Effects Report #5743886-0
Gemzar side effect was reported by a Physician from JAPAN on May 09, 2008. Male patient, weighting 159.8 lb, was diagnosed with bile duct cancer, constipation , prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholangitis acute, haemoglobin decreased, interstitial lung disease, platelet count decreased. Gemzar dosage: 1700 MG, OTHER. During the same period patient was treated with MAGMITT, URSO. Patient was hospitalized. Patient died on 04/08/2008.

Gemzar Side Effects Report #5759612-5
Gemzar side effect was reported by a Physician from JAPAN on May 27, 2008. Female patient, weighting 110.2 lb, was diagnosed with bile duct cancer, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, metastases to lung, metastases to peritoneum. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with SEROTONE, DECADRON, RINDERON, MYSLEE, LEVOTHYROXINE, LOXONIN, CYTOTEC, LANSOPRAZOLE. Patient died on 01/04/2008.

Gemzar Side Effects Report #5891698-X
Gemzar side effect was reported by a Physician from JAPAN on May 27, 2008. Female patient, weighting 110.2 lb, was diagnosed with bile duct cancer, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, metastases to lung, metastases to peritoneum. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with SEROTONE, DECADRON, RINDERON, MYSLEE, LEVOTHYROXINE, LOXONIN, CYTOTEC, LANSOPRAZOLE. Patient died on 01/04/2008.

Gemzar Side Effects Report #6045810-2
Gemzar side effect was reported by a Physician from JAPAN on May 27, 2008. Female patient, weighting 110.2 lb, was diagnosed with bile duct cancer, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, metastases to lung, metastases to peritoneum. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with SEROTONE, DECADRON, RINDERON, MYSLEE, THYRADIN S, LOXONIN, CYTOTEC, TAKEPRON. Patient died on 01/04/2008.

Gemzar Side Effects Report #5800223-0
Gemzar side effect was reported by a Physician from GERMANY on June 20, 2008. Male patient, weighting 207.2 lb, was diagnosed with adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: alveolitis, anaemia, fungal infection , hypertension, interstitial lung disease, leukopenia, neutropenia, orthopnoea, thrombocytopenia. Gemzar dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, ENALAPRIL MALEATE, ENALAPRIL MALEATE, DREISAFER, BELOC ZOK, BELOC ZOK, VERGENTAN, EMBOLEX. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5305769-X
Gemzar side effect was reported by a Physician from JAPAN on Apr 13, 2007. Male patient, 78 years of age, was diagnosed with prophylaxis, hypertension, constipation , pain , abdominal pain upper, insomnia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cough, interstitial lung disease, lymphangiosis carcinomatosa, malignant pleural effusion, pericardial effusion, pulmonary embolism , scan with contrast abnormal. Gemzar dosage: 800 MG/M2, UNK. During the same period patient was treated with RINDERON, ADALAT, DILTIAZEM, MAGLAX, LOXONIN, SELBEX, DEPAS, NASEA. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5369423-0
Gemzar side effect was reported by a Physician from JAPAN on June 19, 2007. Male patient, 78 years of age, was diagnosed with prophylaxis, hypertension, constipation , pain , abdominal pain upper, insomnia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, lymphangiosis carcinomatosa, malignant pleural effusion, pericardial effusion, scan with contrast abnormal. Gemzar dosage: 800 MG/M2, UNK. During the same period patient was treated with RINDERON, ADALAT, DILTIAZEM, MAGLAX, LOXONIN, SELBEX, DEPAS, NASEA. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5308195-2
Gemzar side effect was reported by a Physician from JAPAN on Apr 17, 2007. Male patient, 74 years of age, weighting 121.3 lb, was diagnosed with depression , dyspnoea, insomnia, prophylaxis against gastrointestinal ulcer, back pain , gastritis prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, malignant neoplasm progression, metastases to central nervous system, platelet count decreased, pneumonia , pyrexia, respiratory failure, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with NAVALBINE, MEILAX, PREDONINE, SOLANAX, GASTER D, LOXONIN, SELBEX. Patient was hospitalized. Patient died on 01/05/2007.

Gemzar Side Effects Report #5330851-0
Gemzar side effect was reported by a Physician from JAPAN on May 14, 2007. Male patient, 74 years of age, weighting 121.3 lb, was diagnosed with depression , dyspnoea, insomnia, prophylaxis against gastrointestinal ulcer, back pain , gastritis prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: interstitial lung disease, malignant neoplasm progression, metastases to central nervous system, platelet count decreased, pneumonia , pulmonary fibrosis , pyrexia, respiratory failure, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with NAVALBINE, MEILAX, PREDONINE, SOLANAX, GASTER D, LOXONIN, SELBEX. Patient was hospitalized. Patient died on 01/05/2007.

Gemzar Side Effects Report #5735855-1
Gemzar side effect was reported by a Physician from JAPAN on Apr 30, 2008. Female patient, 70 years of age, was treated with Gemzar. After drug was administered, patient experienced the following side effects: computerised tomogram abnormal, interstitial lung disease. Gemzar dosage: unknown. Patient recovered.